Most sold healthcare stocks in Q4 2023

See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2023, measured as net reductions in reported share positions from Q3 2023 into Q4 2023. Notable reductions at the top of this list include OPTION CARE HEALTH INC (OPCH), ILLUMINA INC (ILMN), AGILON HEALTH INC (AGL), NOVARTIS AG-SPONSORED ADR (NVS). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
OPCHOPTION CARE HEALTH INC-5,889,289-$174.39M01021
ILMNILLUMINA INC-4,778,686-$647.87M11205
AGLAGILON HEALTH INC-4,134,545-$77.18M01203
NVSNOVARTIS AG-SPONSORED ADR-2,852,703-$323.02M23207
WRBYWARBY PARKER INC-CLASS A-2,754,460-$34.43M02103
NVONOVO-NORDISK A/S-SPONS ADR-2,315,219$121.97M02105
BDXBECTON DICKINSON AND CO-2,091,077-$720.63M134110
UNHUNITEDHEALTH GROUP INC-1,499,713-$534.87M2615126
IOVAIOVANCE BIOTHERAPEUTICS INC-1,226,400-$5.58K00010
GILDGILEAD SCIENCES INC-1,221,305$255.55M12609
ARDXARDELYX INC-1,185,273-$4.84K00010
OSCROSCAR HEALTH INC - CLASS A-973,745$29.64M01203
AZNASTRAZENECA PLC-SPONS ADR-922,517$6.98M03205
ALLKALLAKOS INC-835,748-$1.68K00101
PFEPFIZER INC-825,859-$91.20M347115
OPKOPKO HEALTH INC-808,643-$1.29K00010
OCGNOCUGEN INC-674,978-$22600101
IONSIONIS PHARMACEUTICALS INC-674,194$4.58M00303
PINCPREMIER INC-CLASS A-664,090-$13.30K00101
THCTENET HEALTHCARE CORP-627,765-$26.98M01112
ZLABZAI LAB LTD-ADR-621,120-$9.47M01102
BBIOBRIDGEBIO PHARMA INC-584,146$351.68M00011
EXASEXACT SCIENCES CORP-577,939$18.46M10204
SGHTSIGHT SCIENCES INC-575,897-$1.98M01011
TMOTHERMO FISHER SCIENTIFIC INC-546,810$10.55M036211
IDXXIDEXX LABORATORIES INC-540,181$242.52M01416
TGTXTG THERAPEUTICS INC-537,262$2.83K00101
AUPHAURINIA PHARMACEUTICALS INC-528,000-$3.94K00101
IMUXIMMUNIC INC-502,594-$73700101
OFIXORTHOFIX MEDICAL INC-464,572-$3.58M00111
PGENPRECIGEN INC-442,987-$69900101
MRNAMODERNA INC-427,669-$46.42M03013
EWEDWARDS LIFESCIENCES CORP-417,671$13.04M13115
RMDRESMED INC-414,463-$1.37M10021
MOHMOLINA HEALTHCARE INC-409,872-$84.03M01203
HROWHARROW INC-339,878-$6.82K00101
ADMAADMA BIOLOGICS INC-338,620-$21800101
ALTALTIMMUNE INC-330,900-$86000010
BIIBBIOGEN INC-326,996$823.36K02105
HCATHEALTH CATALYST INC-310,200-$2.92M00202
DNLIDENALI THERAPEUTICS INC-305,905-$6.18K00101
CTKBCYTEK BIOSCIENCES INC-296,900-$1.64K00010
TERNTERNS PHARMACEUTICALS INC-290,100-$1.46K00010
SNYSANOFI-ADR-289,273-$324.27M01304
EHABENHABIT INC-261,606-$2.94M00010
CDXSCODEXIS INC-260,286-$49200010
ARWRARROWHEAD PHARMACEUTICALS IN-259,500-$6.52K00101
GSKGSK PLC-SPON ADR-256,188$52.94M03407
PSTXPOSEIDA THERAPEUTICS INC-252,971-$8300101
LNTHLANTHEUS HOLDINGS INC-251,035-$171.84K01011
20 symbols with net change in reported shares from tracked managers.−6.5M−4.9M−3.2M−1.6M0.00Net change in reported shares (tracked managers)OPCHILMNAGLNVSWRBYNVOBDXUNHIOVAGILDARDXOSCRAZNALLKPFEOPKOCGNIONSPINCTHCSymbol

Frequently asked questions about Most sold healthcare stocks in Q4 2023

  • What are the most sold Healthcare stocks in Q4 2023?

    The most sold healthcare stocks in Q4 2023 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q3 2023, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2023?

    Among the managers we track, net reductions were largest in companies such as OPTION CARE HEALTH INC (OPCH), ILLUMINA INC (ILMN), AGILON HEALTH INC (AGL), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2023).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.